Long-term management of asthma: how to improve outcomes.
Improved clinical outcomes in asthma patients have been demonstrated in several clinical trials that applied the National Institutes of Health (NIH) guidelines for the long-term management of asthma. Environmental control, objective monitoring, drug therapy, and partnership in patient education are the major components of optimal management. Inhaled antiinflammatory agents are of major importance for long-term control in patients with persistent asthma. Adequate patient education is absolutely essential for excellent, cost-effective care of patients with asthma. Improved outcomes in adults with asthma have been demonstrated at clinics initiated and managed by pharmacists. Further trials are needed with large numbers of patients in managed care organizations.
Self
T
T
University of Tennessee, Memphis, College of Pharmacy 38163, USA.
Nolan
S
S
D000328:Adult; D018927:Anti-Asthmatic Agents / Q000008:administration & dosage / Q000627:therapeutic use; D001249:Asthma / Q000188:drug therapy* / Q000503:physiopathology; D002986:Clinical Trials as Topic; D003362:Cost-Benefit Analysis; D019468:Disease Management; D004496:Education, Continuing; D006801:Humans; D009316:National Institutes of Health (U.S.); D009330:Nebulizers and Vaporizers; D010353:Patient Education as Topic; D010595:Pharmacists; D017410:Practice Guidelines as Topic; D012129:Respiratory Function Tests; D016896:Treatment Outcome; D014481:United States